{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:09:19Z","timestamp":1778843359693,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100022337","name":"North York General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.preghy.2025.101239","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T21:19:10Z","timestamp":1752787150000},"page":"101239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia: A validation study"],"prefix":"10.1016","volume":"41","author":[{"given":"Tianhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamim","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbo (George)","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel S.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Priston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Bedford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elad","family":"Mei-Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.preghy.2025.101239_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.preghy.2025.101239_b0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: its pathogenesis and pathophysiolgy: review articles","volume":"27","author":"Gathiram","year":"2016","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.preghy.2025.101239_b0015","unstructured":"London: National Institute of Care Excellence (NICE). Hypertension in pregnancy: diagnosis and management for Health. Published online 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546004\/."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000341264","article-title":"Competing risks model in early screening for preeclampsia by biophysical and biochemical markers","volume":"33","author":"Akolekar","year":"2013","journal-title":"Fetal Diagn. Ther."},{"issue":"4","key":"10.1016\/j.preghy.2025.101239_b0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/uog.14819","article-title":"Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening","volume":"46","author":"Park","year":"2015","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101239_b0035","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/297397","article-title":"Early prediction of preeclampsia","author":"Poon","year":"2014","journal-title":"Obstet. Gynecol. Int."},{"issue":"2","key":"10.1016\/j.preghy.2025.101239_b0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ajog.2018.11.1087","article-title":"Predictive performance of the competing risk model in screening for preeclampsia","volume":"220","author":"Wright","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","article-title":"The competing risk approach for prediction of preeclampsia","volume":"223","author":"Wright","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/ajo.12126","article-title":"Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy","volume":"53","author":"Park","year":"2013","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.preghy.2025.101239_b0055","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101239_b0060","unstructured":"BORN. Better Outcomes Registry & Network. Published online 2024. https:\/\/www.bornontario.ca\/en\/index.aspx."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0065","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s12884-022-04514-4","article-title":"Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia","volume":"22","author":"Huang","year":"2022","journal-title":"BMC Preg. Childbirth"},{"issue":"9\u201310","key":"10.1016\/j.preghy.2025.101239_b0070","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/sim.689","article-title":"Multiple imputation in public health research","volume":"20","author":"Zhou","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/j.preghy.2025.101239_b0075","doi-asserted-by":"crossref","unstructured":"A. Gantt T.D. Metz J.A. Kuller J.M. Louis A.G. Cahill M.A. Turrentine, Pregnancy at Age 35 Years or Older ACOG Obstetric Care Consensus No. 11. Obstetr. Gynecol. 140(2) (2022) 348\u2013366.","DOI":"10.1097\/AOG.0000000000004873"},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11+ 0 to 13+ 6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/uog.6280","article-title":"First-trimester maternal serum pregnancy-associated plasma protein-a and pre-eclampsia","volume":"33","author":"Poon","year":"2009","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2025.101239_b0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ajog.2010.06.014","article-title":"Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women","volume":"203","author":"Audibert","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0095","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/uog.7621","article-title":"Maternal plasma soluble endoglin at 11\u201313 weeks\u2019 gestation in pre-eclampsia","volume":"35","author":"Foidart","year":"2010","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0100","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11\u201313 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat. Diagn."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0110","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ajog.2017.10.024","article-title":"First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume","volume":"218","author":"Sonek","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0120","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2025.101239_b0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313 weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0130","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ajog.2019.09.041","article-title":"Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population","volume":"221","author":"Chaemsaithong","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.preghy.2025.101239_b0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/uog.22093","article-title":"Screening for pre-eclampsia at 11\u201313 weeks\u2019 gestation: use of pregnancy-associated plasma protein-a, placental growth factor or both","volume":"56","author":"Mazer Zumaeta","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101239_b0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.22071","article-title":"Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8\u201310 compared with 11\u201313 weeks\u2019 gestation","volume":"57","author":"Mendoza","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.preghy.2025.101239_b0145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/uog.23645","article-title":"Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China","volume":"58","author":"Hu","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2025.101239_b0150","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/uog.24918","article-title":"Impact of replacing or adding pregnancy-associated plasma protein-a at 11\u201313 weeks on screening for preterm pre-eclampsia","volume":"60","author":"Wah","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.preghy.2025.101239_b0155","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/1471-0528.17096","article-title":"Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: adjusting for the effect of aspirin treatment","volume":"129","author":"Wright","year":"2022","journal-title":"BJOG"},{"issue":"7","key":"10.1016\/j.preghy.2025.101239_b0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/pd.4597","article-title":"First trimester screening for down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein a, free-\u03b2 human chorionic gonadotrophin, placental growth factor, and \u03b1-fetoprotein","volume":"35","author":"Huang","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"8","key":"10.1016\/j.preghy.2025.101239_b0165","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/pd.5090","article-title":"Expanded conventional first trimester screening","volume":"37","author":"Carmichael","year":"2017","journal-title":"Prenat. Diagn."},{"issue":"4","key":"10.1016\/j.preghy.2025.101239_b0170","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/uog.15818","article-title":"Maternal serum alpha-fetoprotein at 12, 22 and 32 weeks\u2019 gestation in screening for pre-eclampsia","volume":"47","author":"Bredaki","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.preghy.2025.101239_b0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajog.2019.11.1264","article-title":"First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease","volume":"222","author":"Dinglas","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101239_b0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s13167-020-00212-3","article-title":"A risk model of prenatal screening markers in first trimester for predicting hypertensive disorders of pregnancy","volume":"11","author":"Chen","year":"2020","journal-title":"EPMA J."},{"issue":"6","key":"10.1016\/j.preghy.2025.101239_b0185","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/uog.15849","article-title":"Maternal serum PAPP-A and free \u03b2-hCG at 12, 22 and 32 weeks\u2019 gestation in screening for pre-eclampsia","volume":"47","author":"Wright","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101239_b0190","unstructured":"C. Teixeira, E. Tejera, H. Martins et al., First trimester aneuploidy screening program for preeclampsia prediction in a Portuguese obstetric."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925000558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:27:15Z","timestamp":1778840835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925000558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":38,"alternative-id":["S2210778925000558"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101239","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia: A validation study","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101239","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101239"}}